Journal of Medicinal Chemistry p. 466 - 472 (1988)
Update date:2022-07-29
Topics: In vitro Derivatives Antagonists in vivo High-Throughput Screening Pharmacokinetics Experimental terms Assay Platelet Activating Factor Pharmacodynamics
Tilley, Jefferson W.
Burghardt, Barbara
Burghardt, Charles
Mowles, Thomas F.
Leinweber, Franz-Josef
et al.
A series of N-<(heteroaryl)alkyl>pyrido<2,1-b>quinazolines were evaluated for their ability to inhibit the binding of radiolabeled platelet activating factor (PAF) to its receptor on dog platelets.The most potent compounds in this series were found to be
View MoreXiamen Huasing Chemicals Co.Ltd.
Contact:0086-592-6228397
Address:NO.24, Xinglin North 2nd Road,Jimei district
Suzhou Ryan Pharmachem Technology Co.,Ltd
Contact:+86-0512-68780025
Address:B-301,No.2 Taishan Road,Suzhou New District,Jiangsu,P.R. China
NIGNXIA XINDACHANG TECHNOLOGY CO.,LTD
website:https://xdcchemical.com/
Contact:86-311-85758226
Address:North Industry Area, Wuji
Zhejiang Allied Chemical Co.,Ltd
Contact:18967038207
Address:Area A-30, High-tech Industrial Park, Quzhou, Zhejiang, China.
website:https://www.bocsci.com/
Contact:1-631-485-4226
Address:Ramsey Road
Doi:10.1021/jo00238a021
(1988)Doi:10.1021/ja01574a048
(1957)Doi:10.1039/c39830001082
(1983)Doi:10.1021/jo00238a041
(1988)Doi:10.1021/jo00249a001
(1988)Doi:10.1016/j.ejmech.2008.03.019
(2009)
